Table 1.
Baseline Characteristics (mean ± SD and range) of the Experimental Groups
| Variable | Fenofibrate (n=12) | Rosiglitazone (n=12) | Calorie-Restricted Diet (n=13) | p |
|---|---|---|---|---|
| Age (years) | 55 ± 7 (38–62) |
52 ± 6 (39–64) |
53 ± 7 (39–61) |
0.71 |
| Men | 9 (75%) | 7 (58%) | 7 (54%) | 0.58 |
| Caucasian | 8 (67%) | 8 (67%) | 9 (69%) | 1.0 |
| Body mass index (kg/m2) | 32.8 ± 3.6 (28.3–38.0) |
30.4 ± 3.2 (26.1–36.1) |
30.8 ± 3.2 (25.7–36.7) |
0.19 |
| Waist circumference (cm) | 109 ± 9 (101–122) |
105 ± 14 (85–134) |
102 ± 10 (84–112) |
0.41 |
| Fasting glucose (mg/dl) | 97 ± 7 (85–111) |
99 ± 12 (75–119) |
103 ± 10 (91–124) |
0.27 |
| Fasting insulin (µU/ml) | 10.8 ± 4.7 (6.2–22.4) |
9.6 ± 4.9 (3.8–18.7) |
9.4 ± 2.3 (6.8–15.2) |
0.58 |